N@N

Market Maker Surveillance Report. TNGO, PURE, ABMD, CHTP, ARAY, ENVI, Losing Stocks With Lowest Price Friction For Friday, Sep

September 7, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4076 companies with "abnormal" market making, 3523 companies with positive Friction Factors and 1937 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Tangoe Inc (NASDAQ:TNGO), Pure Bioscience (NASDAQ:PURE), Abiomed Inc (NASDAQ:ABMD), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Accuray Inc (NASDAQ:ARAY), Envivio Inc (NASDAQ:ENVI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  TNGO    $-1.670   -10.46%   1,754,122    47.17%    1,887,987    50.77%    -133,865     -802    
  PURE    $-0.250   -11.27%   65,584       46.49%    69,201       49.05%    -3,617       -145    
  ABMD    $-2.290   -9.83%    749,129      43.93%    919,807      53.94%    -170,678     -745    
  CHTP    $-0.130   -9.03%    423,133      43.70%    545,220      56.30%    -122,087     -9,391  
  ARAY    $-0.700   -10.71%   1,282,029    44.98%    1,545,650    54.23%    -263,621     -3,766  
  ENVI    $-0.480   -17.91%   531,168      40.40%    783,206      59.57%    -252,038     -5,251  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows TNGO with a dollar loss Friday of $-1.67000 and a Friction Factor of -802 shares. That means that it only took 802 more shares of selling than buying to move TNGO lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Tangoe Inc (NASDAQ:TNGO) - TANGO INC

Pure Bioscience (NASDAQ:PURE) - Pure Bioscience, Inc. engages in the development and commercialization of bioscience technologies principally in the United States. The company offers silver dihydrogen citrate (SDC) based antimicrobials. The silver dihydrogen citrate technology is an electrolytically generated source of stabilized ionic silver that could serve as the basis for various products in diverse markets. It also produces SDC as an active pharmaceutical ingredient, which is in clinical trials for multiple indications. In addition, the company provides Axen and Axen30 hard surface disinfectant products for commercial, industrial, and consumer applications, including restaurants, homes, and medical facilities; Axen50 food contact surface sanitizer for sanitization of food contact surfaces and equipment in environments, such as farms, food processing plants, schools, hospitals, restaurants, and homes; and SDC3A disinfectant and food contact surface sanitizer. In addition, it offers SDC-based antimicrobial product; and concentrated SDC-based water treatment product. Pure Bioscience, Inc. sells its products through partners and distributors primarily to industrial and consumer markets. The company was formerly known as Innovative Medical Services and changed its name to Pure Bioscience, Inc. Pure Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Abiomed Inc (NASDAQ:ABMD) - ABIOMED, Inc., together with its subsidiaries, engages in the research, development, and sale of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Its products include Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it provides AbioCor implantable replacement heart, a self-contained artificial heart for end-stage biventricular heart failure patients. Further, the company develops Intra-Aortic Balloon (IAB), an inflatable balloon inserted via a catheter into the patients circulation; iPulse intra-aortic Balloon Catheter, an intra-aortic counterpulsation device that passively unloads the left ventricle, reduces the workload of the heart and enhances cardiac output; and portable circulatory support driver for AB5000 for in-hospital and out-of-hospital patients. It sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, and internationally. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Chelsea Therapeutics International Ltd (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

Accuray Inc (NASDAQ:ARAY) - Accuray Incorporated designs, develops, and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The CyberKnife system combines continuous image-guidance technology with a compact linear accelerator to deliver high doses of radiation to a tumor from different directions. It tracks, detects, and corrects for tumor and patient movement in real-time during the treatment. The CyberKnife systems components and technologies include compact X-band linear accelerator, which generates the radiation to destroy the tumor; robotic manipulator that allows doses of radiation to be delivered from any direction and position; real-time image-guidance system to continuously monitor and correct for patient and tumor movements; X-ray sources to generate X-ray images to determine the location of bony landmarks or implanted fiducials; and image detectors to capture high-resolution anatomical images. The company markets its product through a direct sales force in the United States and a combination of direct sales personnel and distributors internationally. Accuray Incorporated was incorporated in 1990 and is based in Sunnyvale, California.

Envivio Inc (NASDAQ:ENVI) - EnviroResolutions Inc.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net